External site

By following this link, you are leaving Medically and entering a website that is not owned or controlled by Roche. Roche does not take any responsibility for access to or use of this website, nor for any content therein.

Leave site
Home AAO 2023
Roche and Genentech at

AAO 2023

November 03 - November 06
San Francisco, USA
aao.org
Add to calendar
Share feedback
Share page
-
Medical Materials
Agenda
Coming soon
03:00 PM
Duration 5mins San Francisco, USA
Personalized Faricimab▼ Dosing Increased the Proportion of Patients With nAMD Achieving Q16W Dosing in TENAYA/LUCERNE
Chaudhary V, Ambresin A, Kotecha A, Souverain A, Swaminathan B, Margaron P
Ophthalmology | Neovascular Age Related Macular Degeneration

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
Duration 5mins San Francisco, USA
Faricimab▼ Treat-and-Extend–based Dosing Dynamics in the Phase 3 YOSEMITE/RHINE Trials
Lim J, Yonekawa Y, Figueroa M, Pearce I, Gibson K, Jain N, Shildkrot E, Souverain A, Yang M, Willis J, Haskova Z
Ophthalmology | Diabetic Macular Edema

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
Duration 5mins San Francisco, USA
Faricimab▼ Rapidly Dries the Retina in Patients With nAMD
Klein K, Gale R, London N, Kotecha A, Margaron P, Swaminathan B
Ophthalmology | Neovascular Age Related Macular Degeneration

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
Duration 5mins San Francisco, USA
Clinical Outcomes of Patients With DME Presenting With ≤ 20/50 Visual Acuity Treated With Faricimab▼ and Aflibercept
Talcott K, Holekamp N, Zarbin M, Ding A, Tabano D, Lu X, Ahmed A, Yang M, Stoilov I, Amador M
Ophthalmology | Diabetic Macular Edema

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
Duration 5mins San Francisco, USA
Automated Segmentation of Hyperreflective Foci in DME: Greater Volume Reduction With Faricimab▼ in Phase 3 YOSEMITE/RHINE
Singh R, Chakravarthy U, Maunz A, Von Schulthess E, Patel K, Bachmeier I, Jones I, Cohen Y, Gibson K, Glittenberg C, Fauser S
Ophthalmology | Diabetic Macular Edema

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
Duration 5mins San Francisco, USA
Faricimab▼ Reduces Macular Leakage vs Aflibercept in Patients With DME
Kolomeyer A, Eichenbaum D, Sivaprasad S, Nudleman E, Csaky K, Wang T, Haskova Z, Shildkrot E, Amador M, Mar F, Goldberg R, Camino A
Ophthalmology | Diabetic Macular Edema

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
Duration 1min San Francisco, USA
Elevatum Study Design and Rationale: A Phase 4 Trial of Faricimab▼ (VABYSMO) in Underrepresented Patients With DME
Cunningham M, Coney J, Scott A, Amador M, Chang J, Stoilov I, Meldorf M, Gonzalez L
Ophthalmology | Diabetic Macular Edema

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
03:22 PM
Duration 6mins WEST 3004
How Effective is Anti-ANG2 and Anti-VEGF (Faricimab▼) for Neovascular AMD With Pigment Epithelial Detachments?
Jennifer I. Lim - M.D., FARVO
Ophthalmology | Age Related Macular Degeneration

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
03:40 PM
Duration 6mins WEST 3005
Real-world Outcomes and Treatment Patterns With Faricimab▼ in AMD
Sophie J. Bakri - MD.
Ophthalmology | Age Related Macular Degeneration

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
06:41 PM
Duration 6mins WEST 3006
Long Term Clinical Outcomes of anti-VEGF Therapy for Retinal Vein Occlusion: An Overview of Current Data
Michael Ip, MD
Ophthalmology | Retinal Vein Occlusion

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
08:12 PM
Duration 6mins WEST 3006
Clinical Outcomes of Patients With DME Presenting With ≤ 20/50 Visual Acuity Treated With Faricimab▼ and Aflibercept in the YOSEMITE/RHINE Clinical Trials: A Pooled Subcohort Analysis
Marco A. Zarbin - MD, PhD, FACS
Ophthalmology | Age Related Macular Degeneration

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
03:12 PM
Duration 6mins WEST 3006
Regional Variance in the Enrollment of Underrepresented Patients in US Clinical Trials of Diabetic Macular Edema
M. Ali Khan, MD, FACS
Ophthalmology | Diabetic Macular Edema

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar

This website is intended for healthcare professionals outside the United Kingdom (UK) and Australia. Registration status and prescribing information of medicinal products may differ between countries. Please refer to local product information for any medicinal products mentioned on this website.